Drug General Information
Drug ID	D0Z0ZM
Drug Name	SB-202235
Synonyms	139149-55-6; SB-202235; SB-202236
Drug Type	Small molecular drug
Indication	Unspecified		Investigative	[1560115]
Structure		Download 2D MOL 3D MOL
Formula	C16H16N2O4
PubChem Compound ID	11141105
Target and Pathway
Target(s)	Arachidonate 5-lipoxygenase	Target Info	Modulator
BioCyc Pathway	Aspirin-triggered lipoxin biosynthesis
	Resolvin D biosynthesis
	Leukotriene biosynthesis
	Lipoxin biosynthesis
	Aspirin triggered resolvin D biosynthesis
	Aspirin triggered resolvin E biosynthesis
KEGG Pathway	Arachidonic acid metabolism
	Metabolic pathways
	Serotonergic synapse
	Ovarian steroidogenesis
	Toxoplasmosis
NetPath Pathway	IL4 Signaling Pathway
PathWhiz Pathway	Arachidonic Acid Metabolism
WikiPathways	Vitamin D Receptor Pathway
	Arachidonic acid metabolism
	Eicosanoid Synthesis
	Selenium Micronutrient Network
References
Ref 1560115	Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.